BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 22233769)

  • 1. Developmental and reproductive toxicity testing of vaccines.
    Barrow P
    J Pharmacol Toxicol Methods; 2012 Mar; 65(2):58-63. PubMed ID: 22233769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental toxicity testing of vaccines.
    Barrow PC; Allais L
    Methods Mol Biol; 2013; 947():81-9. PubMed ID: 23138897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproductive toxicity testing of vaccines.
    Verdier F; Barrow PC; Burge J
    Toxicology; 2003 Apr; 185(3):213-9. PubMed ID: 12581696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive and developmental toxicity of hydrofluorocarbons used as refrigerants.
    Ema M; Naya M; Yoshida K; Nagaosa R
    Reprod Toxicol; 2010 Apr; 29(2):125-31. PubMed ID: 19914373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The threshold of toxicological concern for prenatal developmental toxicity in rabbits and a comparison to TTC values in rats.
    van Ravenzwaay B; Dammann M; Buesen R; Flick B; Schneider S
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):1-8. PubMed ID: 22705707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies.
    Pentsuk N; van der Laan JW
    Birth Defects Res B Dev Reprod Toxicol; 2009 Aug; 86(4):328-44. PubMed ID: 19626656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproductive toxicology.
    Brent RL
    Reprod Toxicol; 2010 Apr; 29(2):251-3; author reply 254-5. PubMed ID: 19958827
    [No Abstract]   [Full Text] [Related]  

  • 8. Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester.
    Clark RL
    Reprod Toxicol; 2009 Nov; 28(3):285-96. PubMed ID: 19447170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of reproductive toxicity and classification of glufosinate-ammonium.
    Schulte-Hermann R; Wogan GN; Berry C; Brown NA; Czeizel A; Giavini E; Holmes LB; Kroes R; Nau H; Neubert D; Oesch F; Ott T; Pelkonen O; Robert-Gnansia E; Sullivan FM
    Regul Toxicol Pharmacol; 2006 Apr; 44(3 Suppl 1):S1-76. PubMed ID: 16510221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of pharmacokinetic variables in reproductive and developmental toxicity.
    Neubert D
    Xenobiotica; 1988 Jan; 18 Suppl 1():45-58. PubMed ID: 3278490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of human trials to assess developmental immunotoxicity, and some comparison with data on New World monkeys.
    Neubert RT; Webb JR; Neubert D
    Hum Exp Toxicol; 2002; 21(9-10):543-67. PubMed ID: 12458914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal developmental toxicity of decabromodiphenyl ethane in the rat and rabbit.
    Hardy ML; Mercieca MD; Rodwell DE; Stedeford T
    Birth Defects Res B Dev Reprod Toxicol; 2010 Apr; 89(2):139-46. PubMed ID: 20437473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
    Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling the activity of environmental chemicals in prenatal developmental toxicity studies using the U.S. EPA's ToxRefDB.
    Knudsen TB; Martin MT; Kavlock RJ; Judson RS; Dix DJ; Singh AV
    Reprod Toxicol; 2009 Sep; 28(2):209-19. PubMed ID: 19446433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study designs for the nonclinical safety testing of new vaccine products.
    Forster R
    J Pharmacol Toxicol Methods; 2012 Jul; 66(1):1-7. PubMed ID: 22561062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre- and postnatal development in the cynomolgus monkey following administration of ABT-874, a human anti-IL-12/23p40 monoclonal antibody.
    Enright BP; Tornesi B; Weinbauer GF; Blaich G
    Birth Defects Res B Dev Reprod Toxicol; 2012 Dec; 95(6):431-43. PubMed ID: 23212752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
    Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical aspects of including functional endpoints in developmental toxicity studies. Case study: immune function in HuCD4 transgenic mice exposed to anti-CD4 MAb in utero.
    Herzyk DJ; Bugelski PJ; Hart TK; Wier PJ
    Hum Exp Toxicol; 2002; 21(9-10):507-12. PubMed ID: 12458908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive toxicity of BioThrax in rabbits.
    Franco C; Lewis E; Morseth S; Simon L; Waytes AT
    Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):370-6. PubMed ID: 19718687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atenolol developmental toxicity: animal-to-human comparisons.
    Tabacova S; Kimmel CA; Wall K; Hansen D
    Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):181-92. PubMed ID: 12797460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.